Skip to main content
SpringerLink
Log in

DHEA as physiological replacement therapy at menopause

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Labrie F., Bélanger A., Cusan L., Candas B. Physiological changes in DHEA are not reflected by the serum levels of active androgens and estrogens but of their metabolites: intracrinology. J. Clin. Endocrinol. Metab. 82: 2403, 1997.

    Article  PubMed  CAS  Google Scholar 

  2. Bélanger A., Candas B., Dupont A., Cusan L., Diamond P., Gomez J.L., Labrie F. Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J. Clin. Endocrinol. Metab. 79: 1086, 1994.

    PubMed  Google Scholar 

  3. Orentreich N., Brind J.L., Rizer R.L., Vogelman J.H. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J. Clin. Endocrinol. Metab. 59: 551, 1984.

    Article  PubMed  CAS  Google Scholar 

  4. Labrie F., Bélanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 82: 2396, 1997.

    Article  PubMed  CAS  Google Scholar 

  5. Labrie F., Dupont A., Belanger A. Complete androgen blockade for the treatment of prostate cancer. In: de Vita V.T., Hellman S., Rosenberg S.A. (Eds.), Important Advances in Oncology. J.B. Lippincott, Philadelphia, 1985, p. 193.

    Google Scholar 

  6. Bélanger A., Brochu M., Cliche J. Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J. Clin. Endocrinol. Metab. 62: 812, 1986.

    Article  PubMed  Google Scholar 

  7. Labrie F. Intracrinology. Mol. Cell. Endocrinol. 78: C113, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Labrie F., Simard J., Luu-The V., Bélanger A., Pelletier G., Morel Y., Mebarki F., Sanchez R., Durocher F., Turgeon C., Labrie Y., Rheaume E., Labrie C., Lachance Y. The 3-hydroxysteroid dehydrogenase/isomerase gene family: lessons from type II 3β-HSD congenital deficiency. In: Hansson V., Levy F.O., Tasken K. (Eds.), Signal Transduction in Testicular Cells. Ernst Schering Research Foundation Workshopringer-Verlag, Berlin, Heidelberg, New York, 1996, p. 185.

    Chapter  Google Scholar 

  9. Labrie F., Luu-The V., Lin S.X., Labrie C., Simard J., Breton R., Blanger A. The key role of 17β-HSDs in sex steroid biology. Steroids 62: 148, 1997.

    Article  PubMed  CAS  Google Scholar 

  10. Labrie F., Diamond P., Cusan L., Gomez J.L., Belanger A. Effect of 12-month DHEA replacement therapy on bone, vaginum, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab. 82: 3498, 1997.

    Article  PubMed  CAS  Google Scholar 

  11. Biswas M.G., Russell D.W. Expression cloning and characterization of oxidative 17β- and 3α-hydroxysteroid dehydrogenase from rat and human prostate. J. Biol. Chem. 272: 15959, 1997.

    Article  PubMed  CAS  Google Scholar 

  12. Li S., Yan X., Belanger A., Labrie F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat. Cancer Res. Treat. 29: 203, 1993.

    Article  Google Scholar 

  13. Luo S., Labrie C., Labrie F. Prevention of development of dimenthylbenz(a)an-thracene (DMBA)-induced mammary carcinoma in the rat by the new nonsteroidal antiestrogen EM-800. Breast Cancer Res. Treat. in press, 1998.

  14. Couillard S., Labrie C., Belanger A., Candas B., Labrie F. Inhibitory effect of dehydroepiandrosterone and of the novel antiestrogen EM-800 on the growth of human ZR-75-1 breast cancer xenografts in nude mice. J. Natl. Cancer Inst, in press, 1998.

  15. Morales A.J., Nolan J.J., Nelson J.C., Yen S.S. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J. Clin. Endocrinol. Metab. 78: 1360, 1994.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular Endocrinology, Laval University Medical Research Center, Québec, G1V 4G2, Canada

    Fernand Labrie

Authors
  1. Fernand Labrie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Labrie, F. DHEA as physiological replacement therapy at menopause. J Endocrinol Invest 21, 399–401 (1998). https://doi.org/10.1007/BF03350777

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03350777

Key-words

Search

Navigation